Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

Eargo, Inc. (EAR)

Sector - Healthcare

Price chart

N/A
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a medical device company dedicated to improving the quality of life of people with hearing loss. They developed the Eargo solution to create a hearing aid that consumers actually want to use. Their innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. They believe their Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I device for the treatment of hearing loss. Their rapid pace of innovation is enabled by their deep industry and technical expertise across mechanical engineering, product design, audio processing, clinical and hearing science, consumer electronics and embedded software design, and is supported by their strategic intellectual property portfolio. Their differentiated, consumer-first approach empowers consumers to take control of their hearing by improving accessibility, with personalized, high-quality hearing support from licensed hearing professionals. They believe that their differentiated hearing aids, consumer-oriented approach and strong brand have fueled the rapid adoption of their products and high customer satisfaction, as evidenced by over 42,000 Eargo hearing aid systems sold, net of returns, as of June 30, 2020. They believe this represents the beginning of their penetration into a large, growing and underserved market of people with hearing loss, which they estimate included approximately 43 million adults in the United States and more than 465 million adults globally in 2019.
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
CEO CFO
Christian Gormsen Adam Laponis
Employees Founded
184 2010

Contacts

Address: 1600 Technology Drive, 6th Floor San Jose, California 95110

Telephone: (650) 351-7700

Web page: http://www.eargo.com

IPO information

First Trade Date 10/16/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 6.7
Shares Revised (MM) 7.8
Expected offer amount (MM) $100.5
Realized offer amount(MM) $140.4

Financial Data (last reporting year)

Market Cap (MM) $526.5
Revenues (MM) $46.9
Net Income (Loss) (MM) $-43.9

Voting

What do you think will happen with the EAR share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: JP Morgan

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
JP Morgan/ BofA Securities
CO-Managers
Wells Fargo/ William Blair

Sector: Healthcare

Tweets about $EAR

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats